Jun 28, 2018
Sleep-focused neurotech firm Dreem raises $35M from Johnson&Johnson Innovation and Bpifrance
Posted by Alvaro Fernandez in categories: biotech/medical, neuroscience
Dreeming big.
Dreem Announces $35 Million Financing from lead investors Johnson & Johnson Innovation and Bpifrance (press release):
“Dreem, a neurotechnology company, today announced the closing of a new round of funding, raising $35 million USD to rapidly accelerate product development, invest in strategic research and development, and advance the future of sleep technology. Last year, Dreem introduced a comprehensive solution to address a suite of sleep problems and enhance the quality of rest during the night. The Dreem headband monitors brain activity to track sleep accurately and uses auditory stimulation as a medium to help people fall asleep faster, get deeper sleep, and wake up refreshed.